"10.1371_journal.pone.0095993","plos one","2014-05-07T00:00:00Z","Louise M Judd; Treve R Menheniott; Hui Ling; Cameron B Jackson; Meegan Howlett; Anastasia Kalantzis; Waldemar Priebe; Andrew S Giraud","Infection and Immunity Division, Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Pathology and Cancer Research Institute, University of South China, Hengyang, Hunan, China","Conceived and designed the experiments: LMJ TRM ASG. Performed the experiments: LMJ TRM HL CBJ MH AK. Analyzed the data: LMJ TRM ASG. Contributed reagents/materials/analysis tools: WP. Wrote the paper: ASG LMJ ASG TRM WP.","Waldemar Priebe hold patents and has a financial interest in the development of compound WP1066 as follows; W.Priebe, N.Donato, M.Talpaz, S, Szymanski, I. Fokt, A. Levitzki Compounds for the treatment of cell proliferative diseases. Unites States Patent WO/2005/058829 12/01/2004. Note also that the authors have provided an amended statement of Competing Interests regarding a patent on WP1066 held by W. Priebe. The authors also declare that this does not alter our adherence to PLOS ONE policies on sharing data and materials.","2014","05","Louise M Judd","LMJ",8,TRUE,3,6,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
